Expertise in
2
conditions

Estelle Nobecourt

Avenue François Mitterrand, BP 350, 
Saint-quentin-les-marais, FR 
Expertise in
2
conditions
Avenue François Mitterrand, BP 350, 
Saint-quentin-les-marais, FR 

Overview

Estelle Nobecourt practices practicing medicine in Saint-quentin-les-marais, France.

Ms. Nobecourt is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, and Gigantism.

She is actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Avenue François Mitterrand, BP 350, Saint-quentin-les-marais, 97448, France
Other Locations
Saint-pierre-les-bois, France
Nancy, France
Saint-denis-de-palin, France
Saint Pierre Reunion Island, Aix-en-provence, France
Inserm U1188 Diabète Athérothrombose Thérapies Réunion Océan Indien, Inserm U1410, Reunion Island, Island, France
St Pierre De La Reunion, Sete, France
Saint-etienne, France
Nantes, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy
Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy
Enrollment Status: Completed
Publish Date: October 25, 2023
Intervention Type: Other
Study Phase: Not Applicable

42 Total Publications

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real-Life Experience From a National Reference Network.
Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real-Life Experience From a National Reference Network.
Journal: Diabetes, obesity & metabolism
Published: April 09, 2026

Frequently Asked Questions about Estelle Nobecourt

Is Estelle Nobecourt a top-rated expert for Familial Partial Lipodystrophy?

MediFind is an objective health platform that identifies experts based on real-world data. Estelle Nobecourt is classified as an Distinguished expert for Familial Partial Lipodystrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Estelle Nobecourt participate in research or clinical trials?

Yes. Estelle Nobecourt has published 42 articles and abstracts on conditions like Familial Partial Lipodystrophy. You can view a list of Estelle Nobecourt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Nobecourt's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile